Tnf LLC Bristol Myers Squibb CO Transaction History

Tnf LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 12, 2022	SELL	$0.13 - $76.84 $23 - $13,754	-179 Reduced 5.32%	3,184 $218,000
Q2 2022 Jul 25, 2022	BUY	$72.62 - $79.98 $72 - $79	1 Added 0.03%	3,363 $245,000
Q1 2022 Apr 25, 2022	BUY	$61.48 - $73.72 $122 - $147	2 Added 0.06%	3,362 $255,000
Q4 2021 Jan 18, 2022	BUY	$53.63 - $62.52 $180,196 - $210,067	3,360 New	3,360 $218,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Tnf LLC, based on Form 13F filings with the SEC.

Stay updated on Tnf LLC with notifications on news.